Incidence of New Malignancies in Severe Asthma: Comparison of Real-World Patients Treated with Benralizumab, Other Biologics, or Non-biologics.
- DOI
- 10.1007/s41030-026-00379-6
- Published
- 2026 Sep
- Container
- Pulmonary therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s41030-026-00379-6,
title = {Incidence of New Malignancies in Severe Asthma: Comparison of Real-World Patients Treated with Benralizumab, Other Biologics, or Non-biologics.},
author = {Dareng EO and Tran TN and Urbanski H and Finch R and Emerath U and Kurdyukova Y and Jison ML and Bahadori L and Menzies-Gow A and Wang E and Bel EH and de Llano LP and Emmanuel B and Olinger L},
year = {2026},
journal = {Pulmonary therapy},
doi = {10.1007/s41030-026-00379-6},
url = {https://doi.org/10.1007/s41030-026-00379-6}
}RIS
TY - JOUR TI - Incidence of New Malignancies in Severe Asthma: Comparison of Real-World Patients Treated with Benralizumab, Other Biologics, or Non-biologics. AU - Dareng EO AU - Tran TN AU - Urbanski H AU - Finch R AU - Emerath U AU - Kurdyukova Y AU - Jison ML AU - Bahadori L AU - Menzies-Gow A AU - Wang E AU - Bel EH AU - de Llano LP AU - Emmanuel B AU - Olinger L PY - 2026 JO - Pulmonary therapy DO - 10.1007/s41030-026-00379-6 UR - https://doi.org/10.1007/s41030-026-00379-6 ER -
APA
EO, D., TN, T., H, U., R, F., U, E., Y, K., ML, J., L, B., A, M., E, W., EH, B., LP, D. L., B, E., & L, O. (2026). Incidence of New Malignancies in Severe Asthma: Comparison of Real-World Patients Treated with Benralizumab, Other Biologics, or Non-biologics.. Pulmonary therapy. https://doi.org/10.1007/s41030-026-00379-6
Source records
- pubmed · retrieved 2026-09-25T16:31:44.866Z